Proscia is a company that is rewiring pathology for precision medicine to improve patient outcomes. The company's software, artificial intelligence (AI), and real-world data fuel the development and use of novel therapies and diagnostics, driving the fight against humanity’s most challenging diseases, like cancer. Proscia believes that pathology deserves great technology to realize its vast potential to save lives through better, faster diagnoses and new, unprecedented treatments. Proscia’s software is accelerating pathology’s transformation toward a data-driven discipline. The Concentriq® enterprise pathology platform and powerful AI applications are unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care.